Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-15-104619
Filing Date
2015-03-25
Accepted
2015-03-25 12:27:07
Documents
3
Period of Report
2015-05-21

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT d850968dpre14a.htm PRE 14A 564339
2 GRAPHIC g850968pc_001.jpg GRAPHIC 161491
3 GRAPHIC g850968pc_002.jpg GRAPHIC 115445
  Complete submission text file 0001193125-15-104619.txt   947352
Mailing Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011
Business Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011 425-686-1500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 033-80623 | Film No.: 15723982
SIC: 2835 In Vitro & In Vivo Diagnostic Substances